瑞银:维持ZimVie(ZIMV.US)评级,由中性调整至中性评级,目标价由16.00美元调整至10.00美元。ZimVie(ZIMV.US)公司简介:ZimVie Inc专注于牙科和脊柱市场及其各自的增长动力,例如植入物、手术工具、骨移植替代品、脊柱融合植入物、非融合替代品和数字护理管理解决方案。业务分为两个运营部门:脊柱产品部门和牙科产品部门。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.